Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Karen K. Swenson"'
Autor:
Tamera J. Lillemoe, Mara Rendi, Michaela L. Tsai, Monica Knaack, Rina Yarosh, Erin Grimm, Barbara Susnik, Janet Krueger, Susan Olet, Karen K. Swenson
Publikováno v:
International Journal of Breast Cancer, Vol 2021 (2021)
Objectives. The response to HER2-targeted neoadjuvant chemotherapy (NAC) in HER2-positive (+) breast cancer can be quantified using residual cancer burden (RCB) pathologic evaluation to predict relapse free/overall survival. However, more information
Externí odkaz:
https://doaj.org/article/bb78fc25820f448b871f0e9180395daa
Autor:
Mary Vining Radomski, Mattie Anheluk, Ginger L. Carroll, Kim Grabe, Jerry W. Halsten, Kristina Kath, Robert A. Kreiger, Meghan E. Lunos, Stacey Rabusch, Karen K. Swenson, Joette Zola
Publikováno v:
Canadian Journal of Occupational Therapy. 89:115-126
Background. Purpose in life is important to health and well-being; purpose disruption often goes unidentified after breast cancer. Purpose. To evaluate the efficacy of a purpose renewal intervention and utility of a screening question for identifying
Autor:
Helen Garcia, Michele Darger, Shayne Hopkins, M Morrison, Mattie Anheluk, Kim Grabe, Joette Zola, Robert Kreiger, Kristin Berling, Karen K. Swenson, Mary Vining Radomski
Publikováno v:
Clinical Journal of Oncology Nursing. 25:E69-E76
Background Many cancer survivors experience cancer-related cognitive dysfunction (CRCD), which is believed to be the result of multiple contributing biologic, situational, and personal factors. Efficacious, clinically implementable interventions addr
Autor:
Susan Olet, Tamera J. Lillemoe, Barbara Susnik, Janet Krueger, Erin Grimm, Parker Martone, Natasha Rueth, Shari Baldinger, Monica Knaack, Karen K. Swenson, Michaela L. Tsai
Publikováno v:
Clinical Breast Cancer. 21:47-56
Background While breast cancer (BC) is uncommon in women ≤ age 35, women in this age group may have more aggressive cancer subtypes and high-risk pathogenic variants (HRPV). Higher recurrence and mortality rates in young patients may be related to
Autor:
Rob Kreiger, Joette Zola, Kristina Kath, Stacey Rabusch, Jerry Halsten, Mattie Anheluk, Mary Vining Radomski, Karen K Swenson, Ginger Carroll, Barbara L. Zust
Publikováno v:
Journal of Psychosocial Oncology. 38:501-509
This feasibility study evaluated the acceptability, implementability, and preliminary efficacy of a brief purpose renewal intervention (the Compass Course) using a one-group pretest-posttest design. Fifteen women who had completed treatment for early
Publikováno v:
Public health genomics.
Introduction: There is widespread under-identification of individuals at hereditary cancer risk despite national guidelines calling for screening. We evaluated the utilization of a tool embedded in the electronic health record (EHR) to assist primary
Autor:
N Rueth, Karen K. Swenson, M Knaack, Janet Krueger, Barbara Susnik, P Martone, SR Baldinger, Michaela Tsai, Erin Grimm, Tamera J. Lillemoe
Publikováno v:
Cancer Research. 79:P5-10
Background: While breast cancer is rare in women ≤ age 35, patients in this age group are more frequently diagnosed with aggressive cancer subtypes and pathologic germline mutations in cancer susceptibility genes than older patients. Higher recurre
Autor:
Susan Olet, Tamera J. Lillemoe, Monica Knaack, Michaela L. Tsai, Janet Krueger, Mara Hester Rendi, Erin Grimm, Karen K. Swenson, Rina Yarosh, Barbara Susnik
Publikováno v:
International Journal of Breast Cancer, Vol 2021 (2021)
International Journal of Breast Cancer
International Journal of Breast Cancer
Objectives. The response to HER2-targeted neoadjuvant chemotherapy (NAC) in HER2-positive (+) breast cancer can be quantified using residual cancer burden (RCB) pathologic evaluation to predict relapse free/overall survival. However, more information
Autor:
Erinn Downs-Kelly, Barbara Susnik, Karen K. Swenson, Erin V Grimm, Hadi Yaziji, Kimberly H. Allison, Tamera J. Lillemoe, Janet Krueger, Michaela L. Tsai, Mara Hester Rendi, David G. Hicks
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 29(9)
OBJECTIVE College of American Pathologists and the American Society of Clinical Oncology guidelines provide straightforward criteria for HER2 interpretation in breast carcinomas; however, a subset of cases present unusual diagnostic dilemmas. MATERIA
Autor:
Monica Knaack, Natasha Rueth, Barbara Susnik, Tamera J. Lillemoe, Lisa Schneider, Christina Braatz, Michaela Tsai, Janet Krueger, Todd E. DeFor, Karen K. Swenson
Publikováno v:
Journal of Surgical Oncology. 118:221-227
BACKGROUND AND OBJECTIVES Preoperative breast magnetic resonance imaging (B-MRI) staging in newly diagnosed breast cancer increases detection of synchronous contralateral findings, but may result in false-positive outcomes. This study objective was t